Opmed.ai
AI NativeMaking Hospitals Resilient
Est 2022|Valuation $4.5M|Raised $15.5M
Published Jun 25, 2026
| Starting Price | Not publicly listed (enterprise/custom) | Not publicly listed (enterprise) | Not publicly listed (enterprise) |
| Typical Fit | Health systems seeking algorithmic schedule and staffing recommendations across cases/blocks/staff and multi-site capacity balancing | Perioperative leaders seeking a widely adopted OR capacity analytics and recommendation platform | Health systems seeking broader periop automation (e.g., workflow assistants, document routing) |
| Key Strength | Emphasis on optimization algorithms and reported per-OR financial impacts (figures are vendor-published) | Publicly stated adoption metrics and established collateral for KLAS/market references | Broader workflow automation capabilities and published outcome anecdotes in PR materials |
| Key Weakness | Sparse third-party reviews and limited publicly documented security attestations; outcome metrics are largely vendor-reported | Enterprise adoption often requires significant change management; some customers request faster innovation | Outcome anecdotes are commonly PR-driven and may not generalize; scope may be broader than some teams require |
—
Areas where Opmed.ai may provide advantages:
Areas where competitors may be stronger:
Market adoption trends: public vendor pages and press materials indicate differing levels of public adoption disclosure; Opmed.ai does not appear to publish comparable scale metrics on product pages to those shared by some competitors.